英文别名(3R,5S)-5-([1,1′-Biphenyl]-4-ylmethyl)-3-methyl-2-pyrrolidinone; (3R,5S)-5-[(Biphenyl-4-yl)methyl]-3-methylpyrrolidin-2-one; (3R,5S)-5-(4-Biphenylylmethyl)-3-methyl-2-pyrrolidinone; 5-((1,1'-Biphenyl)-4-ylmethyl)-3-methyl-2-pyrrolidinone, (3R,5S)-; (3R,5S)-5-biphenyl-4-ylmethyl-3-methylpyrrolidin-2-one; (3R,5S)-3-methyl-5-[(4-phenylphenyl)methyl]pyrrolidin-2-one; trans-5-([1,1'-Biphenyl]-4-ylmethyl)-3-methylpyrrolidin-2-one; Sacubitril impurity 1; Sacubitril Impurity A; LCZ-696 Impurity 5; 2-Pyrrolidinone, 5-([1,1'-biphenyl]-4-ylMethyl)-3-Methyl-, (3R,5S)-; valsartan + sacubitril impurity; Sacubitril Impurity 37; LCZ696(valsartan + sacubitril) impurity 7; Cyclic impurity of Sacubitril 
